S&P 500
5.187,67 -0,03 (-0,00%) Nasdaq
16.302,76 -29,80 (-0,18%) NIKKEI 225
38.386,95 +184,58 (+0,48%) Dólar/Euro
1,0753 +0,0001 (+0,01%) Petróleo Brent
83,96 +0,38 (+0,45%) Bitcoin EUR
57.397,11 -1.115,45 (-1,91%)
Paradigm Medical Industries, Inc. (PDMI)
Paradigm Medical Industries, Inc.
4273 South 590 West
Salt Lake City, UT 84123
United States
801-977-8970
https://www.paradigm-medical.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 5
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Charles S. Pritchard | Vice President of Sales and Marketing | N/A | N/A | N/A |
Descripción
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.
Gobierno corporativo
El ISS Governance QualityScore de Paradigm Medical Industries, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
